三黄汤加减治疗痰湿热结型多囊卵巢综合征临床观察

叶丽芳; 邵鑫; 刘苏; 徐巍龙; 阮园; 邢莹; 王林杰; 顾春艳

三黄汤加减治疗痰湿热结型多囊卵巢综合征临床观察

1.
南京中医药大学附属医院，江苏南京 210029
2.
南京中医药大学附属第三医院，江苏南京 210001
3.
南京中医药大学整合医学学院，江苏南京 210023
4.
南京中医药大学生命科学与医学院，江苏南京 210023

计量
- 文章访问数: 1437
- HTML全文浏览量: 24
- PDF下载量: 1253
- 被引次数: 0
出版历程
- 收稿日期: 2017-05-10
- 修回日期: 2017-07-01
- 刊出日期: 2017-09-10

Clinical Observation on the Effect of Sanhuang Tang in the Treatment of Polycystic Ovary Syndrome of Phlegm Dampness Heat Accumulation Type

1.
The Affiliated Hospital of Nanjing University of Chinese Medicine, Nanjing, 210029, China
2.
The Third Affiliated Hospital of Nanjing University of Chinese Medicine, Nanjing, 210001, China
3.
School of Integrated Medicine, Nanjing University of Chinese Medicine, Nanjing, 210023, China
4.
School of Life Science and Medicine, Nanjing University of Chinese Medicine, Nanjing, 210023, China

摘要

摘要: 目的观察三黄汤对痰湿热结型多囊卵巢综合征（PCOS）的临床疗效。方法随机将65例痰湿热结型多囊卵巢综合征患者分为中药组和对照组，均采用二甲双胍口服，中药组在此基础上，给予三黄汤颗粒并随症加减口服，进行3月的疗效观察。对治疗前后临床症状、性激素水平、体质量及胰岛素抵抗代谢指标等进行分析。结果加用中药组在改善患者临床症状、性激素水平、月经周期恢复、体质量和胰岛素抵抗指标等方面优于对照组（P<0.05~0.01）。结论加用三黄汤加减组临床疗效优于单用西药对照组。
- 多囊卵巢综合征 /
- 痰湿热结型 /
- 肥胖 /
- 胰岛素抵抗
Abstract: OBJECTIVE To observe the clinical effect of Sanhuang Tang in the treatment of polycystic ovary syndrome (PCOS) of phlegm dampness heat accumulation type. METHODS Sixty-five PCOS patients of phlegm dampness heat accumulation type were randomly divided into the Chinese medicine plus group and the western medicine control group. Both group were taking metformin orally， on the basis of this the Chinese medicine group was also taking Sanhuang Tang granules orally. The clinical effect was observed for three months. Clinical symptoms， sex hormone levels， body mass and insulin resistance metabolic indexes were analyzed before and after the treatment. RESULTS The improvements of clinical symptoms， sex hormone levels， body mass and insulin resistance indexes in the Chinese medicine plus group were better than those in the control group (P<0.05～0.01).CONCLUSIONS The clinical effect of Sanhuang Tang plus group is better than that of the western medicine alone control group.
- polycystic ovarian syndrome /
- phlegm dampness heat accumulation type /
- obesity /
- insulin resistance

HTML全文

参考文献(28)

[1]	曹泽毅.中华妇产科学[M].第3版.北京:人民卫生出版社，2014:2632-2640.
[2]	CAO ZY. Chinese Obstetrics and Gynecology[M]. 3rd Edition. Beijing: People's medical publishing house， 2014: 2632-2640.
[3]	刘璐茜，张丹英，刘益群，等.多囊卵巢综合征的遗传学病因研究进展[J].辽宁中医药大学学报，2016，18(4):112-115.
[4]	LIU LQ， ZHANG DY， LIU YQ， et al. Research progress of genetic etiology of polycystic ovary syndrome[J]. J Liaoning Univ Tradit Chin Med， 2016， 18(4):112-115.
[5]	LI R， ZHANG Q，YANG D，et al. Prevalence of polycystic ovary syndrome in women in China: A large community-based study [J].Hum Reprod，2013，28（9）:2562-2569.
[6]	张萍，滕香宇，王丽华，等.育龄护士多囊卵巢综合征流行病学调查研究[J].中华内分泌代谢杂志，2013，29(3):206-210.
[7]	ZHANG P， TENG XY， WANG LH， et al. The prevalence of polyocystic ovary syndrome in nurses of reproductive age[J]. Chin J Endocrinol Metab， 2013， 29(3):206-210.
[8]	中华医学会妇产科学分会内分泌学组.多囊卵巢综合征的诊断和治疗专家共识[J].中华妇产科杂志，2002， 4(7):553-555.
[9]	Endocrinology Group of Obstetrics and Gynecology Branch， Chinese Medical Association. Expert consensus on diagnosis and treatment of polycystic ovary syndrome[J]. Chin J Obstet Gynecol， 2002， 4(7):553-555.
[10]	LEGRO RS， ARSLANIAN SA，EHRMANN DA， et al. Diagnosis and treatment of polycystic ovary syndrome: an endocrine society clinical practice guideline[J]. J Clin Endocrinol Metab， 2013， 98(12): 4565-4592.
[11]	中药新药临床研究指导原则[M].北京：中国医药科技出版社，2002:14-105.
[12]	Guideline for Clinical Trials of New Patent Chinese Medicines[M]. Beijing: China medical science and technology press， 2002:14-105.
[13]	国家中医药管理局.中医病证诊断疗效标准[M].北京：中国医药科技出版社，2011：62-63.
[14]	State Administration of Traditional Chinese Medicine. TCM Syndrome Diagnosis and Treatment Criteria[M].Beijing: China medical science and technology press， 2011:62-63.
[15]	张广美，周璐璐.中西医结合治疗多囊卵巢综合征的系统评价[J]. 中华中医药学刊，2012，30(7):1462-1464.
[16]	ZHANG GM， ZHOU LL. Systematic evaluation on polycystic ovary syndrome treated with integrating Chinese and western medicine[J]. Chin Arch Tradit Chin Med， 2012， 30(7):1462-1464.
[17]	张仲景.金匮要略[M].北京：人民卫生出版社，2005:61-62.
[18]	ZHANG ZJ. Essentials from the Golden Cabinet[M]. Beijing: Beijing publishing house， 2005:61-62.
[19]	太平惠民和剂局.太平惠民和剂局方[M].北京：人民卫生出版社，2007:134-135.
[20]	The Taiping Imperial Pharmacy. Beneficial Formulas from the Taiping Imperial Pharmacy[M]. Beijing: People's medical publishing house， 2007:134-135.
[21]	高建忠.读《内外伤辨惑论》[M].北京：中国中医药出版社，2015:86-88.
[22]	GAO JZ. Reading Clarifying Doubts about Damage from Internal and External Causes[M]. Beijing: China press of traditional Chinese medicine， 2015:86-88.
[23]	吴智春.金匮泻心汤抗动脉粥样硬化的实验研究[J].中国老年学杂志，2003，7(23):461-462.
[24]	WU ZC. Experimental study of Jinkui Xiexin decoction in anti-atherosclerosis[J]. Chin J Gerontol， 2003， 7(23):461-462.
[25]	舒适，刘小美.小檗碱对2型糖尿病大鼠IRS21/22 p85基因表达的影响[J].浙江中医杂志，2009，44(4):254-257.
[26]	SHU S， LIU XM. Effects of berberine on the expression of IRS21/22p85 gene in type 2 diabetic rats[J]. Zhejiang J Tradit Chin Med， 2009， 44(4):254-257.
[27]	杜宏，邵加庆.早期大黄酸干预对db/db小鼠胰岛功能的影响[J].南方医科大学学报，2011，31(9):1526-1530.
[28]	DU H， SHAO JQ. Effect of early intervention with rhein on islet function in db/db mice[J]. J Southern Med Univ， 2011， 31(9):1526-1530.